Insight Molecular Diagnostics Inc (IMDX)

Insight Molecular Diagnostics Inc Stock (IMDX) Financials Data

*All numbers in millions

Period End Date	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	646.87%0.24	0.03	1.14	0.26	0.52
Cost Of Revenue	382.35%0.08	0.02	0.64	0.12	0.17
Gross Profit	946.67%0.16	0.02	0.50	0.14	0.35
	161.04%11.56	4.43	23.93	11.19	10.19
Research and Development	9.43%4.49	4.95	5.83	3.88	3.28
Depreciation and Amortization	5.39%0.67	0.63	0.56	0.58	0.56
Operating Income/Loss	158.37%-11.40	-4.41	-23.44	-11.05	-9.84
Net Interest Income/Expense	13.04%-0.02	-0.02	-0.03	-0.03	-0.03
Nonoperating Income/Loss	15.45%0.14	0.12	0.48	0.19	0.10
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	162.47%-11.26	-4.29	-22.96	-10.85	-9.74
	162.47%-11.26	-4.29	-22.96	-10.85	-9.74
Attributable To Parent	162.47%-11.26	-4.29	-22.96	-10.85	-9.74
Basic Average Shares	6.46%36.75	34.52	-	32.03	32.02
Diluted Average Shares	6.46%36.75	34.52	-	32.03	32.02
Basic Earnings Per Share	158.33%-0.31	-0.12	-	-0.34	-0.30
Diluted Earnings Per Share	158.33%-0.31	-0.12	-	-0.34	-0.30